Papaverine Hydrochloride recalls
Papaverine Hydrochloride products have been recalled 2 times, most recently on 26 Aug 2026. The recalling company is usually American Regent. The most common reason is sterility.
Total recalls2since 2022
Last 12 months1reported
Class I150% of total
Ongoing1latest 26 Aug 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 50%Class II 1 50%Class III 0 0%
Why papaverine hydrochloride is recalled
Companies
Product types
By year
Ongoing papaverine hydrochloride recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Papaverine HCl Injection, USP, 60 mg/ (30 mg/mL) recalledPapaverine Hydrochloride | American Regent | Particulate Matter | Nationwide |
All papaverine hydrochloride recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Papaverine HCl Injection, USP, 60 mg/ (30 mg/mL) recalledPapaverine Hydrochloride | American Regent | Particulate Matter | Nationwide |
| Drug | CLASS II | Papaverine Hydrochloride Injection, USP, 60 mg/ (30 mg/mL) recalledPapaverine Hydrochloride | Vitae Enim Vitae Scientific | Sterility | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.